Cargando…
Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism
PURPOSE: We recently demonstrated that histone deacetylase (HDAC) inhibitors can “reprogram” differentiated triple-negative breast cancer cells to become quiescent stem-like cancer cells. We hypothesized that the metabolic state of such cells differs from that of their differentiated progeny. RESULT...
Autores principales: | Debeb, Bisrat G., Lacerda, Lara, Larson, Richard, Wolfe, Adam R., Krishnamurthy, Savitri, Reuben, James M., Ueno, Naoto T., Gilcrease, Michael, Woodward, Wendy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053589/ https://www.ncbi.nlm.nih.gov/pubmed/27078845 http://dx.doi.org/10.18632/oncotarget.8631 |
Ejemplares similares
-
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model
por: Lacerda, Lara, et al.
Publicado: (2015) -
Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
por: Hu, Xiaoding, et al.
Publicado: (2021) -
Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models
por: Wolfe, Adam R., et al.
Publicado: (2016) -
The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
por: Xu, Wei, et al.
Publicado: (2013) -
Tetrandrine, a Compound Common in Chinese Traditional Medicine, Preferentially Kills Breast Cancer Tumor Initiating Cells (TICs) In Vitro
por: Xu, Wei, et al.
Publicado: (2011)